| Variables | 5-year cumulative OS | 5-year cumulative DFS |
|---|
| MSD | AD | MSD | AD |
|---|
| Grade II-IV aGVHD |
| Yes | 50.0 ± 35.4 | 30.0 ± 17.5 | 50.0 ± 35.4 | 15.0 ± 13.8 |
| No | 54.4. ± 9.0 | 78.1 ± 6.7 | 44.4 ± 9.3 | 73.6 ± 7.1 |
| P-value | 0.474 | 0.002 | 0.605 | 0.001 |
| Donor-recipient ABO compatibility |
| Compatible | 66.6 ± 12.8 | 55.6 ± 11.4 | 67.0 ± 12.8 | 50.9 ± 11.6 |
| Incompatible | 45.9 ± 11.3 | 83.0. ± 7.1 | 27.7 ± 10.9 | 74.9. ± 8.5 |
| P-value | 0.244 | 0.047 | 0.041 | 0.078 |
| Conditioning regimen |
| Bu/Cy-based | 52.3 ± 10.3 | 77.6 ± 7.1 | 44.1 ± 10.4* | 69.2 ± 7.9* |
| TBI/Cy-based | 60.8 ± 15.8 | 58.7. ± 13.1 | 40.5 ± 19.6* | 58.7 ± 13.1* |
| P-value | 0.777 | 0.023 | 0.854 | 0.093 |
| CMV infection |
| Yes | 44.4 ± 18.9 | 60.9 ± 9.5 | 15.6 ± 14.2* | 57.4 ± 9.7* |
| No | 57.2 ± 9.7 | 85.0. ± 8.2 | 54 ± 9.8* | 75 ± 9.9* |
| P-value | 0.748 | 0.033 | 0.235 | 0.083 |
- * Estimated value censored
